184 related articles for article (PubMed ID: 22938900)
1. The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma.
Boyd CA; Benarroch-Gampel J; Sheffield KM; Han Y; Kuo YF; Riall TS
Surgery; 2012 Sep; 152(3):403-13. PubMed ID: 22938900
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
3. Effects of depression on the survival of pancreatic adenocarcinoma.
Sheibani-Rad S; Velanovich V
Pancreas; 2006 Jan; 32(1):58-61. PubMed ID: 16340745
[TBL] [Abstract][Full Text] [Related]
4. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
[TBL] [Abstract][Full Text] [Related]
5. EUS and survival in patients with pancreatic cancer: a population-based study.
Ngamruengphong S; Li F; Zhou Y; Chak A; Cooper GS; Das A
Gastrointest Endosc; 2010 Jul; 72(1):78-83, 83.e1-2. PubMed ID: 20620274
[TBL] [Abstract][Full Text] [Related]
6. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
[TBL] [Abstract][Full Text] [Related]
7. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
[TBL] [Abstract][Full Text] [Related]
8. In search of lost time: Delays in adjuvant therapy for pancreatic adenocarcinoma among under-resourced patient populations.
Hamad A; Eskander MF; Shen C; Bhattacharyya O; Fisher JL; Oppong BA; Obeng-Gyasi S; Tsung A
Surgery; 2022 Sep; 172(3):982-988. PubMed ID: 35595567
[TBL] [Abstract][Full Text] [Related]
9. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes.
Eskander MF; Hamad A; Li Y; Fisher JL; Oppong B; Obeng-Gyasi S; Tsung A
Surgery; 2022 Mar; 171(3):770-776. PubMed ID: 34876291
[TBL] [Abstract][Full Text] [Related]
10. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study.
Lygidakis NJ; Sgourakis G; Georgia D; Vlachos L; Raptis S
Ann Surg; 2002 Dec; 236(6):806-13. PubMed ID: 12454519
[TBL] [Abstract][Full Text] [Related]
11. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
12. Hospital and medical care days in pancreatic cancer.
Boyd CA; Branch DW; Sheffield KM; Han Y; Kuo YF; Goodwin JS; Riall TS
Ann Surg Oncol; 2012 Aug; 19(8):2435-42. PubMed ID: 22451235
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
14. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
15. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.
Amin S; Lucas AL; Frucht H
Pancreas; 2013 Mar; 42(2):249-53. PubMed ID: 22836862
[TBL] [Abstract][Full Text] [Related]
16. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.
Swords DS; Mulvihill SJ; Brooke BS; Skarda DE; Firpo MA; Scaife CL
Surgery; 2019 Apr; 165(4):751-759. PubMed ID: 30551868
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis of veteran patients with pancreatic cancer.
Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
20. Beyond the dollar: Influence of sociodemographic marginalization on surgical resection, adjuvant therapy, and survival in patients with pancreatic cancer.
Kagedan DJ; Abraham L; Goyert N; Li Q; Paszat LF; Kiss A; Earle CC; Mittmann N; Coburn NG
Cancer; 2016 Oct; 122(20):3175-3182. PubMed ID: 27391466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]